![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Low Health Literacy, Lack of Knowledge, and Self-Control Hinder Healthy Lifestyles in Diverse Patients with Steatotic Liver Disease
In parallel with the obesity and diabetes epidemics, steatotic liver disease (SLD) has emerged as a major global public health concern. The mainstay of therapy is counseling on weight loss and increased exerci...
-
Article
Open AccessCorrection to: Diagnosis and Management of Hepatitis Delta Virus Infection
-
Article
Open AccessDiagnosis and Management of Hepatitis Delta Virus Infection
Hepatitis D virus (HDV) depends on hepatitis B virus (HBV) to enter and exit hepatocytes and to replicate. Despite this dependency, HDV can cause severe liver disease. HDV accelerates liver fibrosis, increases...
-
Article
Acid Test: MELD-Lactate Enhances Prediction in Patients with Variceal Hemorrhage
-
Article
Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers
Hepatitis B (HBV), the leading cause of hepatocellular carcinoma (HCC) worldwide, disproportionately affects minorities in the USA. Undiagnosed HBV precludes HCC screening and contributes to late-stage cancer ...
-
Article
Bacterial Infection in Patients with Cirrhosis: Don’t Get Bugged to Death
Bacterial infection remains a leading cause of mortality and morbidity for patients with cirrhosis, with hospitalization, alterations in the intestinal microbiota, and therapeutic drugs all implicated in its d...
-
Article
Prevention and Management of HBV Infection in Patients with Chronic Kidney Disease Requiring Renal Transplantation
This review addresses clinical challenges of hepatitis B virus (HBV) infection in patients with chronic kidney disease and renal transplant recipients.
-
Article
The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population
Hepatocellular carcinoma (HCC) incidence is increasing at differential rates depending on race. We aimed to identify associations between race and survival after HCC diagnosis in a diverse American population.
-
Article
Heterogeneity of Outcomes Following Liver Transplantation for Primary Sclerosing Cholangitis: Age Matters
-
Article
Current and Potential Future Chemopreventive Strategies Against Hepatitis B Virus Reinfection in Liver Transplant Recipients
Although the availability of effective oral therapies for hepatitis B virus (HBV) infection has reduced the need for liver transplantation (LT) for decompensated cirrhosis due to chronic infection, HBV remains...
-
Article
Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems
Evidence-based guidelines and quality indicators for cirrhosis care have been established. Whether there are variations in adherence to these cirrhosis standards at different specialty settings has not been in...
-
Article
The Diagnostic Yield of Site and Symptom-Based Biopsies for Acute Gastrointestinal Graft-Versus-Host Disease: A 5-Year Retrospective Review
Graft-versus-host disease (GVHD) complicates half of hematopoietic stem cell transplants (HCT), and the gastrointestinal tract is commonly affected. Endoscopic biopsies have a key role in the diagnosis. The op...
-
Article
Does Nucleos(t)ide (NUC) Analogs Therapy in Hepatitis B Impact the Incidence of Liver Cancer?
Hepatocellular carcinoma (HCC) is a major source of mortality. It is the second most common cause of death worldwide, the fifth most common cancer in men, and ninth in women. It is estimated that 782,000 cases...
-
Article
Hepatitis C Virus Infection Increases the Risk of Develo** Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Chronic kidney disease and hepatitis C virus are prevalent in the general population worldwide, and controversy exists about the impact of HCV infection on the development and progression of kidney disease.
-
Article
Low SVR Rates in Clinical Practice for Treating Genotype 1 Chronic Hepatitis C with Protease Inhibitors Boceprevir and Telaprevir
-
Article
De Novo Membrano-Proliferative Nephritis Following Interferon Therapy for Chronic Hepatitis C (Case Study and Literature Review)
-
Article
Primary Care of Patients with Cirrhosis – Current and Future Challenges
Cirrhosis is currently the 12th leading cause of death in the United States and also accounts for considerable morbidity. However many cirrhotic patients can remain well compensated for a protracted period of ...
-
Article
Ethnicity predicts metabolic syndrome after liver transplant
Post-transplant metabolic syndrome (PTMS) is associated with important causes of morbidity and mortality in solid organ transplant recipients. Our aim was to investigate predictors of PTMS in liver transplant ...
-
Article
Management of Patients with Chronic Hepatitis B Before and After Liver Transplantation: An Update
The use of newer and more potent antiviral agents against hepatitis B virus (HBV) results in greater viral suppression; however, liver transplantation is still required for complications of HBV infection. Post...
-
Article
Meta-Analysis: The Impact of Nutritional Status on the Immune Response to Hepatitis B Virus Vaccine in Chronic Kidney Disease
Patients with chronic kidney disease (CKD) typically show a diminished immune response to hepatitis B virus (HBV) vaccine compared with individuals with intact kidney function. A number of inherited or acquire...